The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Cardiovascular effects and molecular targets of resveratrol
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Dudley, J. I., Das, S., Mukherjee, S., & Das, D. K. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.003 · Cited by 117
RetractedMukherjee, S., Lekli, I., Gurusamy, N., Bertelli, A. A. A., & Das, D. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.005 · Cited by 113
RetractedDas, S., Fraga, C. G., & Das, D. K. (2006) · Free Radical Research · doi:10.1080/10715760600833085 · Cited by 112
RetractedTherapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
Cantó, C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., Zierath, J. R., & Auwerx, J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.006 · Cited by 921
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Mattagajasingh, I., Kim, C.-S., Naqvi, A., Yamamori, T., Hoffman, T. A., Jung, S.-B., DeRicco, J., Kasuno, K., & Irani, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704329104 · Cited by 881
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Nitric oxide and oxidative stress in vascular disease
Förstermann, U. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0808-2 · Cited by 781
Self-citationSIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1B
Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., & Zhai, Q. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.014 · Cited by 766
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses
Leonard, S. S., Xia, C., Jiang, B.-H., Stinefelt, B., Klandorf, H., Harris, G. K., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.105 · Cited by 681
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000029925.18593.5c · Cited by 666
Self-citationAMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
Ungvari, Z., Bagi, Z., Feher, A., Recchia, F. A., Sonntag, W. E., Pearson, K., de Cabo, R., & Csiszar, A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00260.2010 · Cited by 568
Resveratrol: A multitargeted agent for age-associated chronic diseases
Harikumar, K. B., & Aggarwal, B. B. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5740 · Cited by 550
Cardiovascular Protective Effects of Resveratrol
Bradamante, S., Barenghi, L., & Villa, A. (2004) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00139.x · Cited by 528
Clinical trials of resveratrol
Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., & Brown, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05853.x · Cited by 522
Resveratrol induces mitochondrial biogenesis in endothelial cells
Csiszar, A., Labinskyy, N., Pinto, J. T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2009 · Cited by 449
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H.-Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019881 · Cited by 437
Resveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426
Su, H.-C., Hung, L.-M., & Chen, J.-K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2005 · Cited by 412
Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K., & Horio, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090266 · Cited by 358
Zhang, Q.-J., Wang, Z., Chen, H.-Z., Zhou, S., Zheng, W., Liu, G., Wei, Y.-S., Cai, H., Liu, D.-P., & Liang, C.-C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn224 · Cited by 349
Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries
Ungvari, Z., Orosz, Z., Labinskyy, N., Rivera, A., Xiangmin, Z., Smith, K., & Csiszar, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01346.2006 · Cited by 348
Resveratrol: One molecule, many targets
Pirola, L., & Fröjdö, S. (2008) · IUBMB Life · doi:10.1002/iub.47 · Cited by 347
Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells
Ungvari, Z., Labinskyy, N., Mukhopadhyay, P., Pinto, J. T., Bagi, Z., Ballabh, P., Zhang, C., Pacher, P., & Csiszar, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00375.2009 · Cited by 341
The red wine hypothesis: from concepts to protective signalling molecules
Opie, L. H., & Lecour, S. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm149 · Cited by 332
Chemosensitization of tumors by resveratrol
Gupta, S. C., Kannappan, R., Reuter, S., Kim, J. H., & Aggarwal, B. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05852.x · Cited by 305
Förstermann, U., & Li, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01196.x · Cited by 300
Self-citationBelguendouz, L., Fremont, L., & Linard, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00820-9 · Cited by 299
Klinge, C. M., Blankenship, K. A., Risinger, K. E., Bhatnagar, S., Noisin, E. L., Sumanasekera, W. K., Zhao, L., Brey, D. M., & Keynton, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411565200 · Cited by 296
Spanier, G., Xu, H., Xia, N., Tobias, S., Deng, S., Wojnowski, L., Förstermann, U., & Li, H. (2009) · PubMed · Cited by 288
Self-citationSulaiman, M., Matta, M. J., Sunderesan, N. R., Gupta, M. P., Periasamy, M., & Gupta, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00418.2009 · Cited by 287
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.003 · Cited by 277
Csiszar, A., Labinskyy, N., Podlutsky, A., Kaminski, P. M., Wolin, M. S., Zhang, C., Mukhopadhyay, P., Pacher, P., Hu, F., de Cabo, R., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2008 · Cited by 276
Csiszar, A., Smith, K., Labinskyy, N., Orosz, Z., Rivera, A., & Ungvari, Z. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00340.2006 · Cited by 274
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway
Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M. K., Gherghiceanu, M., Popescu, L. M., & Das, D. K. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp384 · Cited by 263
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro
Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y., & Wu, J. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.77 · Cited by 244
Anti‐diabetic effects of resveratrol
Szkudelski, T., & Szkudelska, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05844.x · Cited by 240
Resveratrol is a Peroxidase-mediated Inactivator of COX-1 but Not COX-2
Szewczuk, L. M., Forti, L., Stivala, L. A., & Penning, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314302200 · Cited by 240
Resveratrol increases vascular oxidative stress resistance
Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., Podlutsky, A., & Csiszar, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01258.2006 · Cited by 237
LI, Y., CAO, Z., & ZHU, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.08.002 · Cited by 235
Resveratrol in cardiovascular health and disease
Petrovski, G., Gurusamy, N., & Das, D. K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05843.x · Cited by 232
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Dolinsky, V. W., Chan, A. Y. M., Robillard Frayne, I., Light, P. E., Des Rosiers, C., & Dyck, J. R. B. (2009) · Circulation · doi:10.1161/circulationaha.108.787440 · Cited by 232
Cao, Z., & Li, Y. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.031 · Cited by 229
Physiological mechanisms regulating the expression of endothelial-type NO synthase
Li, H., Wallerath, T., & Förstermann, U. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00127-1 · Cited by 223
Self-citationMetabolic networks of longevity
Houtkooper, R. H., Williams, R. W., & Auwerx, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.029 · Cited by 217
SIRT1 Activation by Small Molecules
Dai, H., Kustigian, L., Carney, D., Case, A., Considine, T., Hubbard, B. P., Perni, R. B., Riera, T. V., Szczepankiewicz, B., Vlasuk, G. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133892 · Cited by 211
Resveratrol Improves Endothelial Function: Role of TNFα and Vascular Oxidative Stress
Zhang, H., Zhang, J., Ungvari, Z., & Zhang, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.187146 · Cited by 211
Arunachalam, G., Yao, H., Sundar, I. K., Caito, S., & Rahman, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.080 · Cited by 205
KAGA, S., ZHAN, L., MATSUMOTO, M., & MAULIK, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.08.003 · Cited by 199
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 187
Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice
Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lu, Q., Oelze, M., Torzewski, M., Lackner, K. J., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168724 · Cited by 181
Self-citationHung, L.-M., Su, M.-J., & Chen, J.-K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.016 · Cited by 178
Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1–FoxO1 pathway
Chen, C.-J., Yu, W., Fu, Y.-C., Wang, X., Li, J.-L., & Wang, W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.110 · Cited by 177
Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR
Liu, M., Wilk, S. A., Wang, A., Zhou, L., Wang, R.-H., Ogawa, W., Deng, C., Dong, L. Q., & Liu, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169284 · Cited by 176
Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D., & Netticadan, T. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.228 · Cited by 172
Resveratrol: a cardioprotective substance
Wu, J. M., & Hsieh, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05854.x · Cited by 167
Vetterli, L., Brun, T., Giovannoni, L., Bosco, D., & Maechler, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176842 · Cited by 165
Klinge, C. M., Wickramasinghe, N. S., Ivanova, M. M., & Dougherty, S. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-103366 · Cited by 162
Resveratrol and life extension
Agarwal, B., & Baur, J. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05850.x · Cited by 158
Norata, G. D., Marchesi, P., Passamonti, S., Pirillo, A., Violi, F., & Catapano, A. L. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.047 · Cited by 155
Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Li, H., & Förstermann, U. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058002 · Cited by 154
Self-citationJuan, S., Cheng, T., Lin, H., Chu, Y.-L., & Lee, W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.015 · Cited by 153
Wang, Z., Zou, J., Cao, K., Hsieh, T., Huang, Y., & WU, J. M. (2005) · PubMed · Cited by 152
Miatello, R. M., VAZQUEZ, M., Renna, N. F., Cruzado, M., Zumino, A. Z. P., & Risler, N. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.12.012 · Cited by 152
Shen, M., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D., & Sheu, J. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06788.x · Cited by 143
Vascular Dysfunction in Aging: Potential Effects of Resveratrol, an Anti- Inflammatory Phytoestrogen
Labinskyy, N., Csiszár, A., Veress, G., Stef, G., Pacher, P., Oroszi, G., WU, J. M., & Ungvari, Z. I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360987 · Cited by 140
Das, S., Cordis, G. A., Maulik, N., & Das, D. K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00453.2004 · Cited by 133
Do, G.-M., Kwon, E.-Y., Kim, H., Jeon, S.-M., Ha, T. Y., Park, T., & Choi, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.113 · Cited by 132
Hung, L., Su, M., Chu, W., Chiao, C., Chan, W., & Chen, J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704637 · Cited by 129
MIZUTANI, K., Ikeda, K., Kawai, Y., & Yamori, Y. (2000) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.46.78 · Cited by 125
Zou, J., Wang, Z., Huang, Y., Cao, K., & WU, J. M. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.3.317 · Cited by 119
Haider, U. G. B., Sorescu, D., Griendling, K. K., Vollmar, A. M., & Dirsch, V. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.772 · Cited by 119
Juric, D., Wojciechowski, P. W., Das, D. K., & Netticadan, T. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00852.2006 · Cited by 115
Chow, S., Hshu, Y.-C., Wang, J., & Chen, J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00881.2006 · Cited by 111
Mechanisms of resveratrol-induced platelet apoptosis
Lin, K., Hsiao, G., Shih, C.-M., Chou, D., & Sheu, J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp139 · Cited by 108
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells
de Brito, P. M., Devillard, R., Nègre‐Salvayre, A., Almeida, L. M., Dinis, T. C. P., Salvayre, R., & Augè, N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.011 · Cited by 107
Sılan, C. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.897 · Cited by 104
Stef, G., Csiszár, A., Lerea, K. M., Ungvari, Z. I., & Veress, G. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000238592.67191.ab · Cited by 101
Olas, B., Wachowicz, B., Saluk, J., & Zieliński, T. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00273-6 · Cited by 100
Liu, Z., Yan, S., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., et al. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04303.x · Cited by 88
The controversial links among calorie restriction, SIRT1, and resveratrol
Hu, Y., Liu, J., Wang, J., & Liu, Q. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.034 · Cited by 84
Wojciechowski, P. W., Juric, D., Louis, X. L., Thandapilly, S. J., Yu, L., Taylor, C. G., & Netticadan, T. (2010) · Journal of Nutrition · doi:10.3945/jn.109.115006 · Cited by 83
Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol
Mukhopadhyay, P., Mukherjee, S., Ahsan, M. K., Bagchi, A., Pacher, P., & Das, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015705 · Cited by 82
Zou, J., Huang, Y., Cao, K., Yang, G., Yin, H., Len, J., Hsieh, T., & Wu, J. M. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00925-5 · Cited by 75
Penumathsa, S. V., Koneru, S., Samuel, S. M., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.012 · Cited by 69
Red wine antioxidant resveratrol‐modified cardiac stem cells regenerate infarcted myocardium
Gurusamy, N., Ray, D., Lekli, I., & Das, D. K. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01140.x · Cited by 67
Frombaum, M., Thérond, P., Djelidi, R., Beaudeux, J., Bonnefont‐Rousselot, D., & Borderie, D. (2011) · Free Radical Research · doi:10.3109/10715762.2010.527337 · Cited by 66
Arrick, D. M., Sun, H., Patel, K. P., & Mayhan, W. G. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2011 · Cited by 61
SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy
Li, L., Gao, P., Zhang, H., Chen, H., Zheng, W., Lv, X., Xu, T., Wei, Y., Liu, D., & Liang, C. (2010) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq104 · Cited by 60
Resveratrol Suppresses Tumor Necrosis Factor-α-Induced Fractalkine Expression in Endothelial Cells
Moon, S.-O., Kim, W. K., Sung, M. J., Lee, S., Kang, K. P., Kim, D. H., Lee, S. Y., So, J.-N., & Park, S. K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022392 · Cited by 59
Liu, Z., Song, Y., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., et al. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04299.x · Cited by 55
Kim, J. W., Lim, S., Lee, M. Y., Lee, J. W., Oh, W. K., Kim, S. K., & Kang, K. W. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000016 · Cited by 51
Resveratrol: A Multifunctional Compound Improving Endothelial Function
Li, H., & Förstermann, U. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6209-0 · Cited by 51
Self-citationHaider, U. G. B., Roos, T. U., Kontaridis, M. I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005421 · Cited by 50
Wang, Z., Chen, Y., Labinskyy, N., Hsieh, T., Ungvari, Z. I., & WU, J. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.156 · Cited by 49
Yuan, Q., Peng, J., Liu, S., Wang, C., Xiang, D., Xiong, X., Hu, C., & Li, Y. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05368.x · Cited by 44
MicroRNA signatures of resveratrol in the ischemic heart
Mukhopadhyay, P., Pacher, P., & Das, D. K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05866.x · Cited by 35
Essential role of ER-α-dependent NO production in resveratrol-mediated inhibition of restenosis
Khandelwal, A. R., Hebert, V. Y., & Dugas, T. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00369.2010 · Cited by 34
Schreiner, C. E., Kumerz, M., Geßlbauer, J., Schachner, D., Joa, H., Erker, T., Atanasov, A. G., Heiß, E. H., & Dirsch, V. M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq355 · Cited by 32
Yuan, Q., Chen, L., Xiang, D., Li, Y., & Hu, C. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-069 · Cited by 17
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Health benefits of polyphenols: A concise review
Rana, A., Samtiya, M., Dhewa, T., Mishra, V., & Aluko, R. E. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14264 · Cited by 761
Potential Adverse Effects of Resveratrol: A Literature Review
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062084 · Cited by 716
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Self-citationMarkers of Oxidative Stress during Diabetes Mellitus
Tiwari, B. K., Pandey, K. B., Abidi, A. B., & Rizvi, S. I. (2013) · Journal of Biomarkers · doi:10.1155/2013/378790 · Cited by 517
Metadata
- Authors
- Li, H., Xia, N., & Förstermann, U.
- Venue
- Nitric Oxide
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 26
- Issue
- 2
- Pages
- 102-110
- ISSN
- 1089-8603 (ISSN-L)
- OpenAlex
- W2011814796
- Cited by
- 287
- References
- 112
- FWCI
- 14.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.